EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of gut microbiome and metabolites with onset and treatment response of patients with pemphigus vulgaris

Yiyi Wang, Xuyang Xia, Xingli Zhou, Tongying Zhan, Qinghong Dai, Yan Zhang, Wei Zhang, Yang Shu, Wei Li, Heng Xu

Frontiers in Immunology · 2023

DOI: 10.3389/fimmu.2023.1114586 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Immunology, 2023. Verfasst von Yiyi Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology & Rare Disease Center, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Pemphigus. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gut dysbiosis and gut microbiome-derived metabolites have been implicated in both disease onset and treatment response, but this has been rarely demonstrated in pemphigus vulgaris (PV). Here, we aim to systematically characterize the gut microbiome to assess the specific microbial species and metabolites associated with PV.

Methods

We enrolled 60 PV patients and 19 matched healthy family members, and collected 100 fecal samples (60 treatment-naïve, 21 matched post-treatment, and 19 controls). Metagenomic shotgun sequencing and subsequent quality control/alignment/annotation were performed to assess the composition and microbial species, in order to establish the association between gut microbiome with PV onset and treatment response. In addition, we evaluated short-chain fatty acids (SCFAs) in PV patients through targeted metabolomics analysis.

Results

The diversity of the gut microbiome in PV patients deviates from the healthy family members but not between responder and non-responder, or before and after glucocorticoid treatment. However, the relative abundance of several microbial species, including the pathogenic bacteria (e.g., Escherichia coli ) and some SCFA-producing probiotics (e.g., Eubacterium ventriosum ), consistently differed between the two groups in each comparison. Escherichia coli was enriched in PV patients and significantly decreased after treatment in responders. In contrast, Eubacterium ventriosum was enriched in healthy family members and significantly increased particularly in responders after treatment. Consistently, several gut microbiome-derived SCFAs were enriched in healthy family members and significantly increased after treatment (e.g., butyric acid and valeric acid).

Conclusions

This study supports the association between the gut microbiome and PV onset, possibly through disrupting the balance of gut pathogenic bacteria and probiotics and influencing the level of gut microbiome-derived SCFAs. Furthermore, we revealed the potential relationship between specific microbial species and glucocorticoid treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomePemphigusHumansGlucocorticoidsEubacteriumFatty Acids, VolatileBacteria

Stichwörter der Autor:innen

glucocorticoidmetagemonicmicrobiomepemphigus vulgarisshort-chain fatty acids

Substanzen

GlucocorticoidsFatty Acids, Volatile

Autor:innen und Institutionen

  • Department of Dermatology & Rare Disease Center, West China Hospital, Sichuan University, Chengdu, China.
  • State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Chengdu, China.
  • Department of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Xiangya Hospital, Central South University, Changsha, China.
  • Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Laboratory Medicine, Research Center of Clinical Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.

Zitieren

APA

Wang, Y., Xia, X., Zhou, X., Zhan, T., Dai, Q., Zhang, Y., Zhang, W., Shu, Y., Li, W., & Xu, H. (2023). Association of gut microbiome and metabolites with onset and treatment response of patients with pemphigus vulgaris. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2023.1114586

Vancouver

Wang Y, Xia X, Zhou X, Zhan T, Dai Q, Zhang Y, et al. Association of gut microbiome and metabolites with onset and treatment response of patients with pemphigus vulgaris. Frontiers in Immunology. 2023. doi:10.3389/fimmu.2023.1114586

BibTeX
@article{Wang2023,
  author = {Wang, Yiyi and Xia, Xuyang and Zhou, Xingli and Zhan, Tongying and Dai, Qinghong and Zhang, Yan and Zhang, Wei and Shu, Yang and Li, Wei and Xu, Heng},
  title = {Association of gut microbiome and metabolites with onset and treatment response of patients with pemphigus vulgaris},
  journal = {Frontiers in Immunology},
  year = {2023},
  doi = {10.3389/fimmu.2023.1114586}
}
Kostenlos starten →